Latest filing published 16 Mar 2017 for Ironwood Pharmaceuticals INC.
No signal scores available.
Christopher T. Walsh PhD is a declared insider at 3 companies; the most frequent names are Ironwood Pharmaceuticals Inc, Critical Therapeutics Inc and Kosan Biosciences Inc. Over a trading history stretching from 13 February 2007 to 15 March 2017, the count stands at 29 filings.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 16 March 2017 came the latest disclosure, a share grant in Ironwood Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 27 declarations